Bringing Discoveries to Commercialization
Allinaire Therapeutics Receives Significant Funding

Events

Allinaire Therapeutics Receives Significant Funding

Monday, February 5, 2018

Allinaire Therapeutics, a respiratory therapeutics start-up launched by BioMotiv, has recently received new investments from BioCrossroads’ Indiana Seed Fund and Indiana University’s Innovate Indiana Fund. The Funding will advance the development of therapeutics for the treatment of chronic obstructive pulmonary disorder (COPD) and other respiratory diseases. Read Now